Abstract
Oculomotor assessment is an essential element of the neurological clinical examination and is particularly important when evaluating patients with movements disorders. Most of the brain is involved in oculomotor control, and thus many neurological conditions present with oculomotor abnormalities. Each of the different classes of eye movements and their features can provide important information that can facilitate differential diagnosis. This educational review presents a clinical approach to eye movement abnormalities that are commonly seen in parkinsonism, ataxia, dystonia, myoclonus, tremor, and chorea. In parkinsonism, subtle signs such as prominent square wave jerks, impaired vertical optokinetic nystagmus, and/or the “round the houses” sign suggest early progressive supranuclear gaze palsy before vertical gaze is restricted. In ataxia, nystagmus is common, but other findings such as oculomotor apraxia, supranuclear gaze palsy, impaired fixation, or saccadic pursuit can contribute to diagnoses such as ataxia with oculomotor apraxia, Niemann‐Pick type C, or ataxia telangiectasia. Opsoclonus myoclonus and oculopalatal myoclonus present with characteristic phenomenology and are usually easy to identify. The oculomotor exam is usually unremarkable in isolated dystonia, but oculogyric crisis is a medical emergency and should be recognized and treated in a timely manner. Gaze impersistence in a patient with chorea suggests Huntington's disease, but in a patient with dystonia or tremor, Wilson's disease is more likely. Finally, functional eye movements can reinforce the clinical impression of a functional movement disorder.
Keywords: oculomotor, eye, movement disorders, saccades, pursuit
Extraocular movement assessment is an essential element of the neurological clinical examination as eye movement abnormalities can be of localizing and diagnostic value. During the past few decades, advances in our understanding of the anatomical structures and neuronal networks that control eye movements have provided valuable insights into the underlying neural mechanisms of eye movement—insights that have also been translated into the neural control of limb movements through shared pathophysiological mechanisms of disease. Consequently, the examination of eye movements is valuable in the evaluation of patients with movement disorders. Particularly, neurodegenerative conditions often present with abnormal eye movements with variable semiology. 1 As the diagnosis of the majority of these disorders is based on clinical observation, knowledge of their different eye movement abnormalities is essential.
In this educational review, we provide a brief physiological background on the role of the central nervous system (CNS) in the control of eye movements and summarize these clinical findings across common movement disorders.
Methods
This a nonsystematic educational review of articles extracted from PubMed with several search terms, such as “oculomotor,” “saccades,” “pursuit,” “nystagmus,” “parkinsonism,” “ataxia,” “dystonia,” “myoclonus,” and “tremor.” Selection of the articles was based on their educational value.
Physiology and Anatomy
Eye movements are mainly divided in 2 classes: those that stabilize the image on the fovea—namely, fixation, smooth pursuit, and the vestibulocular and optokinetic reflexes—and those that shift the focus of the fovea toward another area/image of interest, namely, saccades. 1 , 2 The first group are predominantly automatic or reflexive, whereas saccades are usually active components of perception, action, and cognition that support a variety of behavioral functions. Smooth pursuit requires a visible moving target, whereas saccades can be performed with or without visible targets. Saccades are further divided into subcategories; for example, visually guided saccades shift the eyes toward a visual target (suddenly appearing or preexisting), 3 memory‐guided saccades move the eye to a position that used to be occupied by a target, predictive saccades are generated in anticipation of or in search of the appearance of a target at a particular location, and antisaccades move the eye to a mirror location in the opposite direction to a suddenly appearing target. All of those categories of eye movements can be tested at the bedside.
Phenomenology
Saccades
During examination of visually guided saccades, the examiner provides 2 targets (eg, the index fingers of the examiner's 2 hands) within the visual field of the patient and requests the patient to alternate fixation from 1 target to the other. The nature of the elicited saccade depends on the nature of target and the instructions for the task. For example, if the target is suddenly presented, such as wiggling a finger, reflexive saccades are assessed/elicited. Alternatively, if the examiner provides a cue to refixate to stationary targets (eg, auditory, by calling the name of the target) then command voluntary saccades are tested, or if the patient is requested to repetitively refixate between the 2 constantly visible targets in their own time, without cues, then self‐paced saccades are elicited. Memory‐guided saccades are tested by requesting the subject to perform a saccadic movement toward a memorized target in the visual field (the examiner initially presents 2 targets: 1 fixation target and 1 memorized target). Then the memorized target disappears and the patient is asked to move the eyes to the location of the memorized target). The technique for testing saccades should be chosen appropriately each time; for example, in Parkinson's disease (PD), self‐paced or memory‐guided saccades are usually more affected than reflexive saccades, which can be normal (Table 1). 4 The evaluation includes the assessment of saccadic latency (how long it takes for the eyes to start moving following presentation of a cue or target), saccadic velocity (the speed of the eye movement), and saccadic accuracy (whether the eye overshoots or undershoots the target). A mild undershoot followed by a single small corrective saccade to the target may be normal, whereas sustained hypermetria that does not disappear after a few repetitions is always abnormal. 5
TABLE 1.
Clinical pearls
| Oculomotor Findings | Clinical Exam |
|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviations: PD, Parkinson's disease; OKN, optokinetic nystagmus; PSP, progressive supranuclear palsy; CN VI, Cranial Nerve VI.
Oculomotor Apraxia
Leigh and Zee describe acquired ocular motor apraxia as a loss of voluntary control of saccades, pursuit, and vergence, with preservation of reflex movements, especially slow and quick phases of the vestibulo‐ocular reflex. 6 , 7 The term oculomotor apraxia should be used when there is evidence of loss of cerebral control of gaze. In a subgroup of patients, the abnormality is characterized by a spasm of fixation where the eyes cannot move away from a continuously present target but can move when that target disappears. In oculomotor apraxia, the saccadic latency is increased, but multiple factors can affect saccadic latency, such as the salience of the target, the specific instructions to the subject, attention, and the subject's age. 2 , 8 , 9 Therefore, when tested at the bedside, these factors should be taken into account, and increased latency should be reproducible in a large proportion of saccades to be clinically relevant. Disruption of the descending cortical inputs from the frontal and parietal regions to the superior colliculus and then to the brainstem and cerebellum is usually the primary cause of increased saccadic latency in acquired oculomotor apraxia. In patients with prominent oculomotor apraxia, compensatory maneuvers are engaged (such as a head thrust or blink) to assist with breakage of fixation that allows initiation of the saccadic eye movement. If a patient moves the head first and then the eyes during spontaneous gaze, this is usually attributed to oculomotor apraxia, as normally the eyes move first and the head follows.
Fixation Eye Movements
Fixation can be tested at the bedside by providing a stationary target (eg, the examiner's finger). The examiner evaluates the ocular alignment in different positions and looks for abnormal eye movements such as saccadic intrusions or gaze‐evoked nystagmus. There are several classes of normal fixation‐related eye movements, but square wave jerks (SWJs) have been the most studied (Fig. 1). SWJs are normal with a frequency of less than 9 per minute and an amplitude of less than 5 degrees (usually less than 2 degrees). 10 , 11 , 12 , 13 They comprise a small horizontal saccade away from fixation followed by a corrective saccade back to fixation after an intersaccadic interval of about 200 milliseconds. 10 Presence of the intersaccadic interval, the lack of a slow phase (both movements to and from the target are saccadic), and the fact that the eyes do not cross the midline are characteristics that differentiate SWJs from other eye movements such as nystagmus or flutter (busts of horizontal bidirectional back‐to‐back saccades without an intersaccadic interval).
FIG. 1.

Qualitative representation of eye movements during fixation.
Another abnormality of fixation is gaze distractibility or impersistence, which is the inability to maintain fixation by suppressing reflexive saccades to stimuli that appear in the visual field. 14 It is characteristic of Huntington's disease but can also be seen in other conditions such as Wilson's disease. 15
Pursuit Eye Movements
During the assessment of pursuit movements, the eyes follow a smoothly moving target. The examiner assesses how well the eyes match the movement of the target smoothly without the need for corrective movements. When the ocular velocity is lower than the target velocity (reduced pursuit gain), the eyes fall behind, and “catch‐up” saccades are necessary to maintain the eyes on the target.
Optokinetic Nystagmus
Optokinetic nystagmus (OKN) contributes to stabilization of the images on the fovea during head rotations or during tracking of a moving field. It is a normal examination finding, and its absence or a lateralized deficit is abnormal. For testing at the bedside, a rotating drum or a moving tape with stripes or even a bedside heavily illustrated magazine is usually adequate. The slow phase of the OKN is a smooth pursuit movement, and the fast phase is a restorative saccade in the anticompensatory direction—the direction of the inferred head motion—bringing the eyes back to the original position. 16 Depending on the instructions, different types of OKN can be tested. Typically, at the bedside, the “stare” OKN is tested by asking the patient to observe the stripes (or pictures) as they pass in front of him/her. Note that OKN gain (ratio of fast phase velocity to target velocity) depends on many factors including attention, the luminance contrast of the targets, and age of the patient. 17 , 18 , 19
OKN can be particularly useful in identifying subtle impairment of the saccadic or pursuit movements, for example, when asymmetry between left and right horizontal OKN is identified. Vertical OKN has normally lower gain than the horizontal OKN, 2 but marked asymmetry between the horizontal and vertical OKN can be suggestive of vertical eye movement abnormality. For example, in early progressive supranuclear palsy (PSP), the vertical OKN lacks a quick phase and the eyes tend to drift toward the direction of the presented stimuli. 20 In particular, downward saccades are affected first, therefore OKN with upward moving stimuli is mostly affected at the earliest stages of PSP. In contrast, in PD, the gain of OKN induced by downward‐moving stimuli is reduced compared with the OKN with upward‐moving stimuli. 21
Nystagmus
The presence of nystagmus during oculomotor examination is usually abnormal. Nystagmus is classified as either jerk nystagmus or pendular nystagmus. Jerk nystagmus has a slow phase and a fast phase. The slow phase, which takes the eye away from fixation, is the abnormality, with the fast phase being a restorative saccade back toward the intended fixation point. The direction of the nystagmus is traditionally determined by the direction of the fast phase. Pendular nystagmus consists of just slow phases, and the amplitude of the 2 phases is approximately equal. In the movement disorder clinic, pendular nystagmus is seen in Whipple disease or oculopalatal myoclonus, whereas jerk nystagmus can be seen in cerebellar syndromes (Table 2), and many brainstem and peripheral lesions.
TABLE 2.
Cerebellar syndromes, clinical syndromes, and exam
| Localization | Syndrome | Exam Findings |
|---|---|---|
| Flocculus/paraflocculus | Eye fixation impairment | Gaze‐evoked nystagmus, rebound nystagmus and downbeat nystagmus, postsaccadic drift, saccadic pursuit |
| Nodulus/ventral uvula | Vestibulo‐ocular response impairment | Loss of tilt suppression of postrotational nystagmus (after rapid shaking or rotation), periodic alternating nystagmus |
| Dorsal vermis/posterior fastigial nucleus | Saccadic eye movement impairment | Saccadic hypometria (bilateral vermis), saccadic hypermetria (bilateral fastigial nucleus), impairment in the initiation of pursuit |
Vestibular Eye Movements
The vestibular system controls eye movements mainly through the vestibulo‐ocular reflex (VOR). VOR is tested at the bedside by evaluating for a corrective saccade after a passive rapid movement of the head during fixation (head impulse test). Another way is by evaluating nystagmus after head shaking (passive rotational oscillatory shaking of the head while in a 30‐degee neck flexion position, at 2–3 Hz frequency and 10‐degee amplitude, for 10–20 seconds with eyes closed). Dynamic visual acuity is tested by comparing visual acuity while the head is stationary to visual acuity measured during head rotations of approximately 10‐degee amplitude and 2 Hz frequency. Impaired VOR leads to a significant drop of visual acuity during head rotations (1 line loss can be normal, 2–3 lines lost can be seen in unilateral vestibular loss, and 4 or more is typically seen with bilateral vestibular loss). During slow head movements (<1 Hz) with eyes opened, the VOR and optokinetic reflex both stabilize the eyes. However, in cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS), VORs, optokinetic reflexes, and smooth pursuit are deficient; therefore, multiple corrective saccades are evident during low‐frequency head movements (of approximately 0.5 Hz) while the eyes are fixated to a stationary target. 22 , 23 Suppression of the VOR can be tested by evaluating fixation to a head‐fixed target (usually the patient's own thumb with the arm extended) during head (and simultaneous arm) rotation. Abnormalities of the vestibulo‐ocular reflex can cause disequilibrium and oscillopsia. Intact VOR in a patient with gaze palsy points to a supranuclear origin of the gaze palsy.
Eye Movements in Parkinsonism
Oculomotor examination can be helpful in differentiating parkinsonian syndromes (Table 3). In the initial stages of PD, there are no major eye abnormalities on clinical exam in contrast with other parkinsonian syndromes that present with early oculomotor deficits.
TABLE 3.
Patterns of eye movement abnormalities in parkinsonian disorders; some features are shared, whereas others are specific to particular disorders
| Oculomotor abnormalities | PD | MSA | PSP | CBS |
|---|---|---|---|---|
| Progressive gaze limitation | +++ | |||
| Saccadic hypometria | + | ++ | +++ | ++ |
| Slow saccades | +++ | |||
| Saccadic apraxia | ++ | |||
| Impaired SP | +++ | ++ | ++ | |
| Impaired OKN | ++ | +++ | ++ | |
| Increased SWJs | + | ++ | +++ | + |
| Impaired VORS | ++ | + | ||
| Gaze‐evoked nystagmus | +++ | + | ||
| pDBN and ccHSN | +++ |
+, mild; ++, moderate; +++, severe.
Abbreviations: PD, Parkinson's disease; MSA, multiple system atrophy; PSP, progressive supranuclear palsy; CBS, corticobasal syndrome; SP, smooth pursuit; OKN, optokinetic nystagmus; SWJs, square wave jerks; VORS, vestibulo‐ocular reflex suppression (modified from Anderson and MacAskill 1 ); pDBN, positional downbeat nystagmus; ccHSN, cross‐coupled head‐shaking nystagmus.
Saccades are affected in PD and ascribed to abnormal output of the substantia nigra pars reticulata projections to the superior colliculus. 24 Typically, the initial oculomotor abnormality in PD is hypometria of voluntary saccadic eye movement, more in the vertical than the horizontal plane. 25 , 26 One clinical correlate of this abnormality is that hypometric saccades during visual scanning leads to a smaller scanned area, which then leads to an increased risk of falls in patients with PD, especially during turns. 1 , 27 , 28 Self‐paced saccades are usually more affected than reflexive saccades, which appear to be relatively normal, at least for targets close to the center of the visual field. 29 , 30 , 31 , 32 Similar to limb bradykinesia, saccadic bradykinesia with a decrement in saccadic velocity and amplitude over time has also recently been described. 33
If vertical saccadic velocity and amplitude are impaired at the early stages of a parkinsonian syndrome, classical presentation of PSP known as Richardson syndrome (PSP‐RS) should be considered. 34 , 35 , 36 , 37 Normal aging causes restriction of vertical gaze, especially upward, 38 but in PSP‐RS the impairment is more prominent in the downward direction. The earliest sign of PSP‐RS, before gaze restriction occurs, is decreased vertical saccadic velocity. At that stage of the disease, the disproportional slowing of the vertical component compared with the horizontal component causes a curved trajectory during oblique or vertical saccades, classically described as the “round the houses” sign. 39 Later on, there is limitation of voluntary gaze first vertically and then horizontally. Eventually, patients with advanced disease develop complete ophthalmoplegia. 36 OKN testing can help identify early subtle saccadic abnormalities. In PSP‐RS, the fast phase (saccadic phase) of OKN is impaired so that the eyes drift in the direction of the slow phase (pursuit phase). Importantly, other parkinsonian syndromes can cause supranuclear palsy but not as early as PSP‐RS. For example, in corticobasal syndrome with PSP pathology (CBS‐PSP) vertical supranuclear gaze palsy is present in 20% of patients early in the disease and up to 50% overall. 40 In CBS with corticobasal degeneration pathology, vertical supranuclear gaze palsy has been reported between 18% and 59% of late‐stage cases, and it is less common than CBS‐PSP in early stages. 41 , 42 , 43 , 44 , 45 , 46 For a broader differential diagnosis of supranuclear gaze palsy, see Table 4.
TABLE 4.
Differential diagnosis of supranuclear gaze palsy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markedly increased saccadic latency can differentiate CBS from other parkinsonian syndromes such as idiopathic PD, multiple system atrophy (MSA), and PSP. 29 This abnormality in CBS also correlates with limb apraxia scores. 29 Notably, the saccadic velocity is not greatly impaired in CBS, and once saccades are launched, the velocity is usually normal. In contrast, in PD the saccadic latency is generally preserved, at least in the early stages of the disease. However, patients with PD and dementia exhibit prolonged latency compared with those with normal cognition and controls, suggesting that saccadic latency may correlate with cognitive status in PD. 47 , 48
Abnormal fixation is usually nonspecific but can be helpful in differentiating parkinsonian syndromes. SWJs are more frequent in all parkinsonian syndromes, with PSP at the most impaired end of the spectrum (increased SWJ frequency and amplitude 49 ) and PD at the less impaired end. 50 , 51 MSA can also present with more frequent and sometimes large amplitude SWJs (macro‐SWJs). 29 , 52
Smooth pursuit eye movements are generally preserved in early‐stage PD, but abnormal saccadic intrusions appear as the disease progresses. There is evidence that the abnormal saccades during pursuit are not truly “catch up” saccades (as a result of decreased pursuit velocity) but, rather, anticipatory saccades that take the eyes ahead of the moving target, probably reflecting deficits in saccadic inhibition. 32 In PSP, vertical pursuit eye movements are impaired early in the disease, and because of simultaneous impairment of the saccadic system, no catch up saccades can be initiated to compensate for the deficit. 53 Notably, the low‐frequency pursuit movements are initially preserved and only the high‐frequency movements fail. 53
Subtle cerebellar signs, such as presence of nystagmus or saccadic dysmetria, can differentiate MSA from other parkinsonian syndromes. In a series of 25 MSA cases, downbeat nystagmus with Dix‐Hallpike positioning (positional nystagmus) was found in 10 cases, even in patients with no other cerebellar signs on examination. 54 , 55 Because downbeat nystagmus (positional or induced by head shaking) is uncommon in PD, this sign can be useful in differentiating MSA and PD. 54 , 56 In MSA, the saccadic hypometria is mild–moderate, and it is not associated with low velocity (velocity is usually normal). 29 , 54
Finally, convergence insufficiency is common in PD, especially in patients with cognitive impairment (https://collections.lib.utah.edu/ark:/87278/s6p29vr1). 57 , 58 , 59 It can cause blurred near vision, which can significantly impact the quality of life. Convergence training is a treatment option. 60
Eye Movements in Some Ataxia Syndromes
Ataxia Telangiectasia
Ataxia telangiectasia is a multisystem autosomal recessive disorder attributed to mutation of the ATM gene. 61 , 62 The neurological manifestations in ataxia telangiectasia include a cerebellar syndrome (ataxia, impaired coordination, speech disturbance, gait impairment). Other movement disorders such as dystonia, chorea, tremor, and myoclonus can also occur later in the disease. 63 An eye exam is particularly important for recognition of telangiectasias on the sclera and for the characteristic eye movement abnormalities, which are mainly impaired fixation caused by pathologic torsional and downbeat nystagmus and impaired saccades caused by increased latency and dysmetria. In addition, pursuit movements are saccadic, and OKN is abnormal as a result of eye deviation toward the direction of the slow component. 64 , 65 The presence of nystagmus and prominent saccadic intrusions lead to impaired visual fixation, which is hypothesized to be the cause of poor quality of vision in ataxia telangiectasia. 66
Ataxia with Oculomotor Apraxia
There are multiple types of ataxia with oculomotor apraxia, but type I and type II are the most common. 67 , 68 , 69 Both types are autosomal recessive conditions attributed to mutations in the APTX and SETX genes, respectively, 67 , 68 , 69 and onset is earlier in type I (early childhood) compared with type II (teenage years). As the name reveals, oculomotor apraxia is the most prominent oculomotor disorder as reflected in prolonged saccadic latencies. 70 However, this feature is present only in 50% to 60% of the patients. 67 , 68 , 69 Other oculomotor abnormalities include saccadic pursuit and dysmetric saccades (hypometric and hypermetric) as well as increased antisaccade error rates. 70 Cerebellar ataxia is the most common movement disorder in these patients, but other hyperkinetic and hypokinetic movement disorders can occur. Severe peripheral neuropathy and characteristic blood abnormalities can aid diagnosis. 68 , 69 , 70 , 71 , 72
Niemann‐Pick Type C
Niemann‐Pick type C (NPC) is a lysosomal storage disorder with autosomal recessive pattern of inheritance. The symptoms vary and can include psychiatric symptoms, cognitive decline, dysarthria, dysphagia, gelastic cataplexy, hypotonia, seizures, and movement disorders. 73 , 74 , 75 Most common movement disorders are ataxia and dystonia, but myoclonus, chorea, and tremor can also be present. 76 , 77 Supranuclear gaze palsy, especially in the vertical plane, is the most characteristic abnormality in NPC. 78 In particular, downward saccades are affected first (controlled unilaterally) followed by upward saccades (controlled bilaterally). Supranuclear gaze palsy carries high clinical significance for the diagnosis of NPC as it occurs early in the disease 79 and can lead to disease‐specific treatment. 80 , 81
Spinocerebellar Ataxia
Overall the oculomotor abnormalities in spinocerebellar ataxia (SCA) reflect cerebellar pathology with or without involvement of other brain regions and can be useful for differentiating the different genotypes. 1 In SCA 2, the most significant oculomotor sign is reduced saccadic velocity, which correlates with the number of CAG repeats and is thought to be attributed to brainstem involvement. 82 , 83 , 84 , 85 SCA 2 also presents frequently with supranuclear gaze palsy. 86 SCA 3 can present with vertical supranuclear ophthalmoplegia with normal horizontal saccades at least at the initial stages of the disease. 86 , 87 Furthermore, bulging eyes are characteristic of SCA 3. 88 , 89 Besides nystagmus, SCA 6 can present with impaired smooth pursuit even in the presymptomatic stage. 90 Gaze‐evoked and rebound nystagmus are present in many SCA subtypes, but they appear to be particularly common in SCA 3 and SCA 6, with positioning downbeat nystagmus being a specific feature of SCA 6 (https://collections.lib.utah.edu/ark:/87278/s6vx45m7 and https://collections.lib.utah.edu/ark:/87278/s60k7jb4). 91 , 92 , 93 , 94 , 95 In SCA 7, the retinal manifestations can be preceded by oculomotor abnormalities mainly affecting saccadic accuracy and velocity. 96 , 97 , 98
Eye Movements in Myoclonus
Opsoclonus Myoclonus
Opsoclonus was initially described by Orzechowski in 1927 99 and later Kinsbourne, who introduced the term “dancing eyes.” 100 Opsoclonus is classically described as conjugate, involuntary, rapid, nonrhythmic, and chaotic movements of the eyes (https://collections.lib.utah.edu/ark:/87278/s6cw0k1c). 101 It comprises back‐to‐back multidirectional saccades without an intersaccadic interval. Typically it presents in childhood with acute or subacute onset, and it is commonly associated with encephalitis or posterior fossa tumors, mostly neuroblastoma. 102 , 103 In adults, it is associated with paraneoplastic syndromes. 104 , 105 The pathophysiology is presumed to be immune mediated, although the exact mechanism is unclear. 106 , 107 It is thought that opsoclonus is attributed to instability in the fine balance between the omnipause and burst neurons in the brainstem that normally generate the saccadic eye movements. 108 Opsoclonus can be associated with limb myoclonus. As it settles, opsoclonus may metamorphose into ocular flutter (bursts of horizontal bidirectional back‐to‐back saccades without an intersaccadic interval), and opsoclonus and ocular flutter can co‐occur in many instances.
Oculopalatal Myoclonus
Guillain and Mollaret first described the syndrome of palatal myoclonus, and they pointed out that it can be caused by lesions along the dentato‐rubro‐olivary pathway (Guillain‐Mollaret triangle). 109 Palatal myoclonus is usually rhythmical; therefore, the term palatal tremor is sometimes used. There are 2 forms of palatal myoclonus. The first form is essential palatal myoclonus, which is usually isolated with no associated symptoms except for an ear‐clicking sound and has recently been identified to commonly have functional etiology. 110 The other form is symptomatic palatal myoclonus, which is secondary to a lesion in the Guillain‐Mollaret triangle, and it can affect the oculomotor system and other body parts such as the diaphragm. The symptoms of symptomatic palatal myoclonus can occur weeks to months after the lesion. 111 When palatal myoclonus is associated with abnormal eye movements, the most common abnormality is pendular nystagmus. Usually the nystagmus presents in the vertical plane, but a horizontal or rotational component might be present. 112 , 113 Convergent–divergent nystagmus has also been reported. 114 Typically, the palatal and ocular movements have the same frequency and phase. 115 The amplitude of the abnormal eye movements has been reported as large as 8 degrees. 116 The most accepted pathophysiologic mechanism of symptomatic palatal myoclonus is that a CNS lesion along the dentato‐rubro‐olivary pathway causes denervation of the olivary nucleus. Once released from cerebellar inhibitory input, the olivary nucleus enlarges and develops sustained synchronized oscillations, which are fed back to the cerebellum for further modulation and eventually cause the abnormal movements.
Whipple Disease
Whipple disease is caused by an infection with Tropheryma whipplei and mainly causes gastrointestinal or other systemic symptoms. It can affect the CNS, and its neurological manifestations are variable. Insidious neuropsychiatric and cognitive symptoms are most commonly present with the second most common neurological finding being the oculomotor disturbance. 117 , 118 , 119 In particular, oculomasticatory myorhythmia is thought to be a pathognomonic sign for Whipple disease. 117 , 118 It is characterized by oscillatory convergent–divergent movements of the eyes with a frequency of approximately 1 Hz accompanied by synchronous oscillatory contractions of the muscles of mastication (https://collections.lib.utah.edu/ark:/87278/s6tq8z4m). 120 When these movements spread further to the face or the extremities, the term oculofacial‐skeletal myorhythmia is more appropriate. 121 , 122 Supranuclear ophthalmoplegia mimicking PSP can also occur. 119 Usually a hyperkinetic movement disorder such as myoclonus, chorea, or dystonia is also part of the clinical picture. 123 , 124
Prion Disease
Prions are abnormal misfolded proteins that can cause transmissible and genetic neurodegenerative diseases. 125 In humans, prions can cause Creutzfeldt‐Jakob disease (CJD) and its variant, as well as Gerstmann‐Sträussler‐Scheinker syndrome, fatal familial insomnia (FFI), and Kuru. Early ocular motor findings have been reported in patients with CJD. 126 Centripetal nystagmus (during eccentric gaze: fast phase toward primary gaze and slow phase toward eccentric position), 127 breakdown of saccades, and gaze deviation are the most prominent features. 126 , 128 , 129 Vertical supranuclear ophthalmoplegia in CJD can resemble PSP. 128 , 130 Although not commonly reported, ocular dipping can also be a characteristic ocular abnormality. 131 , 132 Disordered fixation with saccadic intrusions in the setting of severe insomnia can be a useful early diagnostic clue of FFI. 133 Gerstmann‐Sträussler‐Scheinker disease also presents with abnormal eye movements in the early stages such as pathologic nystagmus, impaired visual tracking, impaired VOR, and gaze‐evoked nystagmus. At the late stages of the disease, almost all patients have a variety of ocular movement abnormalities. 134
Eye Movements in Dystonia
Isolated Dystonia
Bedside examination of oculomotor function in isolated cervical dystonia is usually normal. However, there is evidence of asymmetric vestibulo‐ocular reflexes and other subtle abnormalities when tested in the laboratory. 135 , 136 Similarly, the eye movements in patients with blepharospasm are largely normal when tested at the bedside,132 but more detailed testing in the laboratory has revealed impairment of saccadic initiation with longer saccadic latencies, although peak velocities and accuracy are normal. 138 In addition, SWJs and macro‐SWJs, as well as vertical and horizontal involuntary deviations and convergence spasms, have been described in blepharospasm. 139
Oculogyric Crisis
Oculogyric crisis (OGC) is a rare disorder characterized by dystonic conjugate eye deviation. 140 , 141 , 142 The etiology is usually attributed to medication adverse effects. The most common medication class associated with OGC is neuroleptics, although other classes have also been associated (for a comprehensive list of medications related to OGC see Barow et al 140 ). Although OGC is typically described as a dystonic movement, it is not typically seen in primary dystonia, and rarely can be associated with blepharospasm. 139 It can be seen in other movement disorders, mainly parkinsonism (especially postencephalitic and disorders of dopamine synthesis), but also focal brain lesions (eg, striatal necrosis), immune encephalitides, and some pediatric genetic disorders (eg, CACNA1A mutations).
Stiff Person Syndrome
Stiff person syndrome (SPS) is characterized by progressive fluctuating muscle spasms usually affecting the axial muscles of the lower back and abdomen. 63 Antibodies directed against glutamic acid decarboxylase, anti‐amphiphysin, anti‐glycine receptor, anti‐DPPX, and other antibodies, have been associated with SPS. 143 , 144 The pathophysiology is thought to be related to impairment of inhibitory GABAergic spinal networks, 145 but there is also evidence of cortical 146 and brainstem 147 involvement. Oculomotor impairment is not always part of the clinical picture, but there are reports that SPS can present with a variety of eye movement abnormalities such as strabismus causing diplopia attributed to horizontal gaze limitation, deficient gain of pursuit movements, increased saccadic latency, and gaze‐evoked nystagmus. 148 , 149 In addition, “stiff eyes” can be part of the SPS phenomenology and represent restriction of the range of extraocular movements in the vertical or horizontal plane, leading to erroneous consideration of PSP. 150 , 151 Fatiguability of saccadic latency, velocity, and accuracy in SPS can differentiate it from PSP. The pathophysiology of “stiff eyes” is unclear, but intravenous immunoglobulin (IVIG) can be helpful therapeutically. 150 , 152
Eye Movements in Tremor
Wilson's Disease
Wilson's disease is an autosomal recessive condition attributed to mutation in the ATP7B gene leading to excessive accumulation of copper in the liver and the brain. In a series of 34 patients, impairment of vertical pursuit was found in 85% of the patients and of horizontal pursuit in 41% of the patients. The next most common abnormality was impaired vertical OKN in 41% of the cohort. 153 Supranuclear upgaze palsy and reduced saccadic velocity have also been reported. 154 Gaze distractibility or impersistence, similar to Huntington's disease, has been described by Wilson himself 15 and more recently by Lennox and Jones. 155 Antisaccades can have increased error rate and latency. 156 The link between the ocular abnormalities and the pathology in Wilson's disease remains unclear. The eye exam is also important for the identification of Kayser‐Fleischer rings.
Eye Movements in Chorea
Huntington's Disease
Huntington's disease is caused by an autosomal dominant CAG trinucleotide repeat expansion in chromosome 4. It manifests with chorea and other involuntary movements, gait disturbance, incoordination, and psychiatric and cognitive problems. The earliest oculomotor finding is prolonged voluntary saccadic latency attributed to oculomotor apraxia, requiring occasional blink or head thrust for saccadic initiation. 14 , 157 , 158 In addition, fixation is impaired because of a failure to inhibit saccades toward stimuli within the visual field. 14 Eccentric gaze holding is also impaired as the eyes tend to be brought back to the primary gaze by an inappropriate saccade. 14 Slow saccades can be seen early in the disease, especially in those with a high CAG repeat number, but usually after other generalized motor impairments. 159 Otherwise, saccades can be hypometric in both the vertical and horizontal planes. 158 Smooth pursuit movements can also be affected by reduced gain, but usually later in the disease. 160 Oculomotor exam is of high yield in Huntington's disease and can be proven essential when hyperkinetic movement disorder with early psychiatric or cognitive findings is encountered.
Functional Eye Movements
Functional eye movement disorders can present in isolation or in the setting of other functional syndromes. 161 , 162 Convergence spasm is likely the most common functional oculomotor disorder 163 and presents with persistence of convergence despite the absence or removal of a near fixation target. It can be confused with cranial nerve VI palsy, but it can be differentiated by observing normal abduction and the associated miosis during accommodation, which are not present with a sixth nerve palsy. 162 , 164 , 165 , 166 Functional limitation of gaze can be accompanied by eyelid fluttering on attempted eye movements, and patients commonly have effortful facial expressions. 162 Voluntary saccadic oscillations such as voluntary (or functional) nystagmus usually cannot be maintained for more than 25 seconds, a helpful feature in differentiating functional from nonfunctional movements. 167 , 168 In addition, other functional movement disorders such as functional opsoclonus, OGC, and ocular flutter have been described. 169 The oculomotor abnormalities encountered in functional eye movement disorders are distractible and variable, similar to functional movements affecting other body parts.
Conclusions
Eye movement abnormalities are highly varied in movement disorders and affect many different mechanisms. A systematic approach to the examination is recommended to avoid missing crucial observations. Fixation should be assessed for at least 15 seconds to assess for SWJs. Horizontal and vertical pursuit and saccades should always be examined. OKN can be a useful supplement but needs careful interpretation if attention is a concern. Abnormal VOR points to vestibular or cerebellar abnormalities or both (such as in CANVAS).
Author Roles
1. Research Project: A. Conception, B. Organization, C. Execution; 2. Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique.
P.K.: 1A, 1B, 1C, 2A
D.K.: 2B
T.A.: 2B
M.H.: 1A, 1B, 1C, 2B
Disclosures
Ethical Compliance Statement: No institutional review board approval and informed patient consent were necessary for this work. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
Funding Sources and Conflicts of Interest: The authors declare that no specific funding was received for this work and that there are no conflicts of interest relevant to this work. P.K. and M.H. conducted this work in the course of official duty as employees of the NIH, an agency of the US federal government. This work was supported by the Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke.
Financial Disclosures for the Previous 12 Months: P.K. and D.K. have nothing to disclose. T.A. is employed by the University of Otago and Anderson Neurology Ltd. and has received research support from the Health Research Council of New Zealand and Brain Research New Zealand–Rangahau Roro Aotearoa. M.H. is an inventor of patents held by the National Institutes of Health (NIH) for an immunotoxin for the treatment of focal movement disorders and the H‐coil for magnetic stimulation; in relation to the latter, he has received license fee payments from the NIH (from Brainsway). He is on the Medical Advisory Boards of CALA Health and Brainsway. He has research grants from Allergan for studies of methods to inject botulinum toxins; Medtronic, Inc. for a study of DBS for dystonia; and CALA Health for studies of a device to suppress tremor.
References
- 1. Anderson TJ, MacAskill MR. Eye movements in patients with neurodegenerative disorders. Nat Rev Neurol 2013;9(2):74–85. [DOI] [PubMed] [Google Scholar]
- 2. Leigh RJ, Zee DS. The Neurology of Eye Movements. 4th ed. New York: Oxford University Press; 2006. [Google Scholar]
- 3. Shibasaki H, Hallett M. The Neurological Examination: Scientific Basis for Clinical Diagnosis. New York: Oxford University Press; 2016. [Google Scholar]
- 4. Terao Y, Fukuda H, Hikosaka O. What do eye movements tell us about patients with neurological disorders? An introduction to saccade recording in the clinical setting. Proc Jpn Acad Ser B Phys Biol Sci 2017;93(10):772–801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Irving EL, Steinbach MJ, Lillakas L, Babu RJ, Hutchings N. Horizontal saccade dynamics across the human life span. Invest Ophthalmol Vis Sci 2006;47(6):2478–2484. [DOI] [PubMed] [Google Scholar]
- 6. Trobe JD. Acquired ocular motor apraxia in hypoxic‐ischemic encephalopathy. Neuro‐ophthalmology Virtual Education Library 2021. https://collections.lib.utah.edu/ark:/87278/s64v2kqk. Published 2021. Accessed February 9th 2022 [Google Scholar]
- 7. Leigh RJ, Zee DS. The Neurology of Eye Movements. New York: Oxford University Press; 2015. [Google Scholar]
- 8. Bonnet C, Hanuska J, Rusz J, et al. Horizontal and vertical eye movement metrics: what is important? Clin Neurophysiol 2013;124(11):2216–2229. [DOI] [PubMed] [Google Scholar]
- 9. Isotalo E, Lasker AG, Zee DS. Cognitive influences on predictive saccadic tracking. Exp Brain Res 2005;165(4):461–469. [DOI] [PubMed] [Google Scholar]
- 10. Lemos J, Eggenberger E. Saccadic intrusions: review and update. Curr Opin Neurol 2013;26(1):59–66. [DOI] [PubMed] [Google Scholar]
- 11. Herishanu YO, Sharpe JA. Normal square wave jerks. Invest Ophthalmol Vis Sci 1981;20(2):268–272. [PubMed] [Google Scholar]
- 12. Abadi RV, Gowen E. Characteristics of saccadic intrusions. Vision Res 2004;44(23):2675–2690. [DOI] [PubMed] [Google Scholar]
- 13. Shallo‐Hoffmann J, Sendler B, Muhlendyck H. Normal square wave jerks in differing age groups. Invest Ophthalmol Vis Sci 1990;31(8):1649–1652. [PubMed] [Google Scholar]
- 14. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington's disease. Neurology 1983;33(10):1268–1275. [DOI] [PubMed] [Google Scholar]
- 15. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the LIVER1. Brain 1912;34(4):295–507. [DOI] [PubMed] [Google Scholar]
- 16. Brune T, Gold DR. Optokinetic nystagmus. Neuro‐Ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6k68htv. 2018.
- 17. Wang L, Soderberg PG, Tengroth B. Influence of target direction, luminance and velocity on monocular horizontal optokinetic nystagmus. Acta Ophthalmol 1993;71(5):578–585. [DOI] [PubMed] [Google Scholar]
- 18. Cheng M, Outerbridge JS. Optokinetic nystagmus during selective retinal stimulation. Exp Brain Res 1975;23(2):129–139. [DOI] [PubMed] [Google Scholar]
- 19. Paige GD. Senescence of human visual‐vestibular interactions. 1. Vestibulo‐ocular reflex and adaptive plasticity with aging. J Vestib Res 1992;2(2):133–151. [PubMed] [Google Scholar]
- 20. Garbutt S, Riley DE, Kumar AN, Han Y, Harwood MR, Leigh RJ. Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75(10):1386–1394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Knapp CM, Gottlob I, McLean RJ, Rajabally YA, Abbott RJ, Rafelt S, Proudlock FA. Vertical optokinetic nystagmus in Parkinson's disease. Mov Disord 2009;24(10):1533–1538. [DOI] [PubMed] [Google Scholar]
- 22. Gold DK, Kung NH & Van Stavern G Abnormal visually‐enhanced VOR in cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS). Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6s50fth. 2017.
- 23. Szmulewicz DJ, Waterston JA, MacDougall HG, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video‐oculographic diagnosis. Ann N Y Acad Sci 2011;1233:139–147. [DOI] [PubMed] [Google Scholar]
- 24. Terao Y, Fukuda H, Yugeta A, et al. Initiation and inhibitory control of saccades with the progression of Parkinson's disease—changes in three major drives converging on the superior colliculus. Neuropsychologia 2011;49(7):1794–1806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. White OB, Saint‐Cyr JA, Tomlinson RD, Sharpe JA. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. Brain 1983;106(Pt 3):571–587. [DOI] [PubMed] [Google Scholar]
- 26. Shibasaki H, Tsuji S, Kuroiwa Y. Oculomotor abnormalities in Parkinson's disease. Arch Neurol 1979;36(6):360–364. [DOI] [PubMed] [Google Scholar]
- 27. Clark US, Neargarder S, Cronin‐Golomb A. Visual exploration of emotional facial expressions in Parkinson's disease. Neuropsychologia 2010;48(7):1901–1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Matsumoto H, Terao Y, Furubayashi T, et al. Small saccades restrict visual scanning area in Parkinson's disease. Mov Disord 2011;26(9):1619–1626. [DOI] [PubMed] [Google Scholar]
- 29. Vidailhet M, Rivaud S, Gouider‐Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35(4):420–426. [DOI] [PubMed] [Google Scholar]
- 30. Briand KA, Strallow D, Hening W, Poizner H, Sereno AB. Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 1999;129(1):38–48. [DOI] [PubMed] [Google Scholar]
- 31. Chambers JM, Prescott TJ. Response times for visually guided saccades in persons with Parkinson's disease: a meta‐analytic review. Neuropsychologia 2010;48(4):887–899. [DOI] [PubMed] [Google Scholar]
- 32. Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol 2009;256(9):1438–1446. [DOI] [PubMed] [Google Scholar]
- 33. Koohi N, Bancroft MJ, Patel J, Castro P, Akram H, Warner TT, Kaski D. Saccadic bradykinesia in Parkinson's disease: preliminary observations. Mov Disord 2021;36(7):1729–1731. [DOI] [PubMed] [Google Scholar]
- 34. Chen AL, Riley DE, King SA, et al. The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 2010;1:147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Buttner‐Ennever JA, Leigh RJ. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 2001;57(11):2070–2077. [DOI] [PubMed] [Google Scholar]
- 36. Troost BT, Daroff RB. The ocular motor defects in progressive supranuclear palsy. Ann Neurol 1977;2(5):397–403. [DOI] [PubMed] [Google Scholar]
- 37. Gold D. Ocular motor signs in progressive supranuclear palsy (PSP). Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s60p4nv0. 2017.
- 38. Chamberlain W. Restriction in upward gaze with advancing age. Am J Ophthalmol 1971;71(1 Pt 2):341–346. [DOI] [PubMed] [Google Scholar]
- 39. Quinn N. The "round the houses" sign in progressive supranuclear palsy. Ann Neurol 1996;40(6):951. [DOI] [PubMed] [Google Scholar]
- 40. Ling H, de Silva R, Massey LA, et al. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 2014;40(2):149–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Murray R, Neumann M, Forman MS, et al. Cognitive and motor assessment in autopsy‐proven corticobasal degeneration. Neurology 2007;68(16):1274–1283. [DOI] [PubMed] [Google Scholar]
- 42. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112(Pt 5):1171–1192. [DOI] [PubMed] [Google Scholar]
- 43. Rinne JO, Lee MS, Thompson PD, Marsden CD, Corticobasal degeneration . A clinical study of 36 cases. Brain 1994;117(Pt 5):1183–1196. [DOI] [PubMed] [Google Scholar]
- 44. Marsden CD, Donaldson I. Marsden's Book of Movement Disorders. Oxford: Oxford University Press; 2012. [Google Scholar]
- 45. Kouri N, Murray ME, Hassan A, et al. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 2011;134(Pt 11):3264–3275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Ling H, O'Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re‐evaluation. Brain 2010;133(Pt 7):2045–2057. [DOI] [PubMed] [Google Scholar]
- 47. Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005;128(Pt 6):1267–1276. [DOI] [PubMed] [Google Scholar]
- 48. Macaskill MR, Graham CF, Pitcher TL, et al. The influence of motor and cognitive impairment upon visually‐guided saccades in Parkinson's disease. Neuropsychologia 2012;50(14):3338–3347. [DOI] [PubMed] [Google Scholar]
- 49. Otero‐Millan J, Serra A, Leigh RJ, Troncoso XG, Macknik SL, Martinez‐Conde S. Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy. J Neurosci 2011;31(12):4379–4387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Rascol O, Sabatini U, Simonetta‐Moreau M, Montastruc JL, Rascol A, Clanet M. Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991;54(7):599–602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Shaikh AG, Xu‐Wilson M, Grill S, Zee DS. “Staircase” square‐wave jerks in early Parkinson's disease. Br J Ophthalmol 2011;95(5):705–709. [DOI] [PubMed] [Google Scholar]
- 52. Klotz L, Klockgether T. Multiple system atrophy with macrosquare‐wave jerks. Mov Disord 2005;20(2):253–254. [DOI] [PubMed] [Google Scholar]
- 53. Joshi AC, Riley DE, Mustari MJ, Cohen ML, Leigh RJ. Selective defects of visual tracking in progressive supranuclear palsy (PSP): implications for mechanisms of motion vision. Vision Res 2010;50(8):761–771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Anderson T, Luxon L, Quinn N, Daniel S, Marsden DC , Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord 2008;23(7):977–984. [DOI] [PubMed] [Google Scholar]
- 55. Gold D. Positional downbeat nystagmus mimicking anterior canal BPPV. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6zp7vx6. 2017.
- 56. Lee JY, Lee WW, Kim JS, Kim HJ, Kim JK, Jeon BS. Perverted head‐shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov Disord 2009;24(9):1290–1295. [DOI] [PubMed] [Google Scholar]
- 57. Irving EL, Chriqui E, Law C, et al. Prevalence of convergence insufficiency in Parkinson's disease. Mov Disord Clin Pract 2017;4(3):424–429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Holden SK, Van Dok E, Pelak VS. Co‐occurrence of convergence insufficiency and cognitive impairment in Parkinsonian disorders: a pilot study. Front Neurol 2019;10:864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Wray SH. Convergence insufficiency. neuro‐ophthalmology virtual education library. https://collections.lib.utah.edu/ark:/87278/s6p29vr1 Published 1993. Accessed February 7th 2022.
- 60. Machan CM, Chriqui E, Law C, et al. Changing vergence function in persons with Parkinson's disease and convergence insufficiency. Parkinsonism Relat Disord 2020;73:41–43. [DOI] [PubMed] [Google Scholar]
- 61. Perlman S, Becker‐Catania S, Gatti RA. Ataxia‐telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 2003;10(3):173–182. [DOI] [PubMed] [Google Scholar]
- 62. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep 2004;5(8):772–776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Fahn S, Jankovic J, Hallett M. Principles and Practice of Movement Disorders. 2nd ed. New York: Elsevier/Saunders; 2011. [Google Scholar]
- 64. Baloh RW, Yee RD, Boder E. Eye movements in ataxia‐telangiectasia. Neurology 1978;28(11):1099–1104. [DOI] [PubMed] [Google Scholar]
- 65. Lewis RF, Crawford TO. Slow target‐directed eye movements in ataxia‐telangiectasia. Invest Ophthalmol Vis Sci 2002;43(3):686–691. [PubMed] [Google Scholar]
- 66. Shaikh AG, Marti S, Tarnutzer AA, et al. Gaze fixation deficits and their implication in ataxia‐telangiectasia. J Neurol Neurosurg Psychiatry 2009;80(8):858–864. [DOI] [PubMed] [Google Scholar]
- 67. Renaud M, Moreira MC, Ben Monga B, et al. Clinical, biomarker, and molecular delineations and genotype‐phenotype correlations of ataxia with oculomotor apraxia type 1. JAMA Neurol 2018;75(4):495–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Anheim M, Monga B, Fleury M, et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain 2009;132(Pt 10):2688–2698. [DOI] [PubMed] [Google Scholar]
- 69. Le Ber I, Moreira MC, Rivaud‐Pechoux S, et al. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003;126(Pt 12):2761–2772. [DOI] [PubMed] [Google Scholar]
- 70. Mariani LL, Rivaud‐Pechoux S, Charles P, et al. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video‐oculography and alpha‐fetoprotein. Sci Rep 2017;7(1):15284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Criscuolo C, Chessa L, Di Giandomenico S, et al. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology 2006;66(8):1207–1210. [DOI] [PubMed] [Google Scholar]
- 72. Date H, Onodera O, Tanaka H, et al. Early‐onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001;29(2):184–188. [DOI] [PubMed] [Google Scholar]
- 73. Sevin M, Lesca G, Baumann N, et al. The adult form of Niemann‐pick disease type C. Brain 2007;130(Pt 1):120–133. [DOI] [PubMed] [Google Scholar]
- 74. Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS. Vertical supranuclear gaze palsy in Niemann‐pick type C disease. Neurol Sci 2012;33(6):1225–1232. [DOI] [PubMed] [Google Scholar]
- 75. Wraith JE, Sedel F, Pineda M, et al. Niemann‐pick type C suspicion index tool: analyses by age and association of manifestations. J Inherit Metab Dis 2014;37(1):93–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Anheim M, Lagha‐Boukbiza O, Fleury‐Lesaunier MC, et al. Heterogeneity and frequency of movement disorders in juvenile and adult‐onset Niemann‐pick C disease. J Neurol 2014;261(1):174–179. [DOI] [PubMed] [Google Scholar]
- 77. Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP‐C patients: findings from an international disease registry. Orphanet J Rare Dis 2013;8:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Solomon D, Winkelman AC, Zee DS, Gray L, Buttner‐Ennever J. Niemann‐pick type C disease in two affected sisters: ocular motor recordings and brain‐stem neuropathology. Ann N Y Acad Sci 2005;1039:436–445. [DOI] [PubMed] [Google Scholar]
- 79. Wijburg FA, Sedel F, Pineda M, et al. Development of a suspicion index to aid diagnosis of Niemann‐pick disease type C. Neurology 2012;78(20):1560–1567. [DOI] [PubMed] [Google Scholar]
- 80. Alobaidy H. Recent advances in the diagnosis and treatment of Niemann‐pick disease type C in children: a guide to early diagnosis for the general pediatrician. Int J Pediatr 2015;2015:816593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, NP‐C Guidelines Working Group . Recommendations for the diagnosis and management of Niemann‐pick disease type C: an update. Mol Genet Metab 2012;106(3):330–344. [DOI] [PubMed] [Google Scholar]
- 82. Velazquez‐Perez L, Seifried C, Santos‐Falcon N, et al. Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann Neurol 2004;56(3):444–447. [DOI] [PubMed] [Google Scholar]
- 83. Wadia NH, Swami RK. A new form of heredo‐familial spinocerebellar degeneration with slow eye movements (nine families). Brain 1971;94(2):359–374. [DOI] [PubMed] [Google Scholar]
- 84. Wadia N, Pang J, Desai J, Mankodi A, Desai M, Chamberlain S. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis. Brain 1998;121(Pt 12):2341–2355. [DOI] [PubMed] [Google Scholar]
- 85. Geiner S, Horn AK, Wadia NH, Sakai H, Buttner‐Ennever JA. The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia‐subtype). Prog Brain Res 2008;171:575–581. [DOI] [PubMed] [Google Scholar]
- 86. Buttner N, Geschwind D, Jen JC, Perlman S, Pulst SM, Baloh RW. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol 1998;55(10):1353–1357. [DOI] [PubMed] [Google Scholar]
- 87. Durr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado‐Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996;39(4):490–499. [DOI] [PubMed] [Google Scholar]
- 88. Moro A, Munhoz RP, Arruda WO, Raskin S, Teive HA. Clinical relevance of "bulging eyes" for the differential diagnosis of spinocerebellar ataxias. Arq Neuropsiquiatr 2013;71(7):428–430. [DOI] [PubMed] [Google Scholar]
- 89. Paulson H, Shakkottai V. Spinocerebellar Ataxia Type 3. 1998 Oct 10 [Updated 2020 Jun 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1196/ [PubMed] [Google Scholar]
- 90. Christova P, Anderson JH, Gomez CM. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol 2008;65(4):530–536. [DOI] [PubMed] [Google Scholar]
- 91. Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J, Giugliani R. Neurologic findings in Machado‐Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol 2001;58(6):899–904. [DOI] [PubMed] [Google Scholar]
- 92. Gomez CM, Thompson RM, Gammack JT, et al. Spinocerebellar ataxia type 6: gaze‐evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997;42(6):933–950. [DOI] [PubMed] [Google Scholar]
- 93. Yabe I, Sasaki H, Takeichi N, Takei A, Hamada T, Fukushima K, Tashiro K. Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003;250(4):440–443. [DOI] [PubMed] [Google Scholar]
- 94. Gold D. Ocular Motor Signs in SCA 6. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6vx45m7. Published 2017. Accessed February 7th 2022.
- 95. Gold D. Spinocerebellar Ataxia Type 3 with Gaze‐Evoked Nystagmus and Bilateral Vestibular Loss. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s60k7jb4. Published 2020. Accessed February 7th 2022.
- 96. Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP. Neuro‐ophthalmologic features of spinocerebellar ataxia type 7. J Neuroophthalmol 2009;29(3):180–186. [DOI] [PubMed] [Google Scholar]
- 97. Manrique RK, Noval S, Aguilar‐Amat MJ, Arpa J, Rosa I, Contreras I. Ophthalmic features of spinocerebellar ataxia type 7. J Neuroophthalmol 2009;29(3):174–179. [DOI] [PubMed] [Google Scholar]
- 98. Oh AK, Jacobson KM, Jen JC, Baloh RW. Slowing of voluntary and involuntary saccades: An early sign in spinocerebellar ataxia type 7. Ann Neurol 2001;49(6):801–804. [DOI] [PubMed] [Google Scholar]
- 99. De Orzechowski K. l'ataxie dysmétrique des yeux: Remarques sur l'ataxie des yeux dite myoclonique (opsoclonie, opsochorie). J Psychol Neurol 1927;35:1–18. [Google Scholar]
- 100. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962;25(3):271–276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Trobe JD. Opsoclonus. Neuro‐ophthalmology Virtual Education Library. 2021. https://collections.lib.utah.edu/ark:/87278/s6cw0k1c. Published 2021. Accessed February 7th 2022
- 102. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident opso‐myoclonus and neuroblastoma. Cancer 1976;37(2):846–852. [DOI] [PubMed] [Google Scholar]
- 103. Blaes F, Dharmalingam B. Childhood opsoclonus‐myoclonus syndrome: diagnosis and treatment. Expert Rev Neurother 2016;16(6):641–648. [DOI] [PubMed] [Google Scholar]
- 104. Musunuru K, Kesari S. Paraneoplastic opsoclonus‐myoclonus ataxia associated with non‐small‐cell lung carcinoma. J Neurooncol 2008;90(2):213–216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Klaas JP, Ahlskog JE, Pittock SJ, et al. Adult‐onset opsoclonus‐myoclonus syndrome. Arch Neurol 2012;69(12):1598–1607. [DOI] [PubMed] [Google Scholar]
- 106. Pike M. Opsoclonus‐myoclonus syndrome. Handb Clin Neurol 2013;112:1209–1211. [DOI] [PubMed] [Google Scholar]
- 107. Oh SY, Kim JS, Dieterich M. Update on opsoclonus‐myoclonus syndrome in adults. J Neurol 2019;266(6):1541–1548. [DOI] [PubMed] [Google Scholar]
- 108. Zee DS, Robinson DA. A hypothetical explanation of saccadic oscillations. Ann Neurol 1979;5(5):405–414. [DOI] [PubMed] [Google Scholar]
- 109. Guillain G, Mollaret P. Deux cas de myoclonies synchrones et rythmées vélo‐pharyngo‐laryngo‐oculodiaphragmatiques. Le probleme anatomique et physio‐pathologique de ce syndrom. Révue Neurologique 1931;2:545–566. [Google Scholar]
- 110. Stamelou M, Saifee TA, Edwards MJ, Bhatia KP. Psychogenic palatal tremor may be underrecognized: reappraisal of a large series of cases. Mov Disord 2012;27(9):1164–1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Matsuo F, Ajax ET. Palatal myoclonus and denervation supersensitivity in the central nervous system. Ann Neurol 1979;5(1):72–78. [DOI] [PubMed] [Google Scholar]
- 112. Tilikete C, Desestret V. Hypertrophic olivary degeneration and palatal or oculopalatal tremor. Front Neurol 2017;8:302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Deuschl G, Toro C, Valls‐Sole J, Zeffiro T, Zee DS, Hallett M. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994;117(Pt 4):775–788. [DOI] [PubMed] [Google Scholar]
- 114. Galvez‐Ruiz A, Roig C, Muñoz S, Arruga J. Convergent‐divergent nystagmus as a manifestation of oculopalatal tremor. Neuro‐Ophthalmology 2011;35(5–6):276–279. [Google Scholar]
- 115. Williams L. Oculopalatal myoclonus. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6fz07rz. 2011.
- 116. Tilikete C, Jasse L, Pelisson D, Vukusic S, Durand‐Dubief F, Urquizar C, Vighetto A. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 2011;76(19):1650–1657. [DOI] [PubMed] [Google Scholar]
- 117. Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 1996;40(4):561–568. [DOI] [PubMed] [Google Scholar]
- 118. Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986;20(6):677–683. [DOI] [PubMed] [Google Scholar]
- 119. Anderson M. Neurology of Whipple's disease. J Neurol Neurosurg Psychiatry 2000;68(1):2–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Wray SH. Oculomasticatory Myorhythmia. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6tq8z4m. Published 2007. Accessed February 7th 2022.
- 121. Simpson DA, Wishnow R, Gargulinski RB, Pawlak AM. Oculofacial‐skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature. Mov Disord 1995;10(2):195–200. [DOI] [PubMed] [Google Scholar]
- 122. Hausser‐Hauw C, Roullet E, Robert R, Marteau R. Oculo‐facio‐skeletal myorhythmia as a cerebral complication of systemic Whipple's disease. Mov Disord 1988;3(2):179–184. [DOI] [PubMed] [Google Scholar]
- 123. Palma JA, Luquin MR, Riverol M, Irimia P, Fernandez‐Alonso M, Tejada J, Martinez‐Vila E. Primary Whipple disease of the CNS presenting with chorea and dystonia: a video case report. Neurol Clin Pract 2014;4(6):508–510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Stamboulis E, Kararizou E, Manta P, Grivas I. Segmental myoclonus in Whipple's disease. Electromyogr Clin Neurophysiol 1995;35(2):113–116. [PubMed] [Google Scholar]
- 125. Prusiner SB. Molecular biology of prion diseases. Science 1991;252(5012):1515–1522. [DOI] [PubMed] [Google Scholar]
- 126. Grant MP, Cohen M, Petersen RB, Halmagyi GM, McDougall A, Tusa RJ, Leigh RJ. Abnormal eye movements in Creutzfeldt‐Jakob disease. Ann Neurol 1993;34(2):192–197. [DOI] [PubMed] [Google Scholar]
- 127. Gold D. Gaze‐evoked and centripetal nystagmus in Creutzfeldt‐Jakob Disease. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s66x3hrw. 2018.
- 128. Yokota T, Tsuchiya K, Yamane M, Hayashi M, Tanabe H, Tsukagoshi H. Geotropic ocular deviation with skew and absence of saccade in Creutzfelt‐Jakob disease. J Neurol Sci 1991;106(2):175–178. [DOI] [PubMed] [Google Scholar]
- 129. Helmchen C, Buttner U. Centripetal nystagmus in a case of Creutzfeldt‐Jacob disease. Neuro‐Ophthalmology. 1995;15(4):187–192. [Google Scholar]
- 130. Josephs KA, Tsuboi Y, Dickson DW. Creutzfeldt‐Jakob disease presenting as progressive supranuclear palsy. Eur J Neurol 2004;11(5):343–346. [DOI] [PubMed] [Google Scholar]
- 131. Sierra‐Hidalgo F, Llamas S, Gonzalo JF, Sanchez Sanchez C. Ocular dipping in Creutzfeldt‐Jakob disease. J Clin Neurol 2014;10(2):162–165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Jeong SH, Kim SY, Park SH, Kim JS. Ocular dipping in Creutzfeldt‐Jakob disease. J Neuroophthalmol 2008;28(4):293–295. [DOI] [PubMed] [Google Scholar]
- 133. Mastrangelo V, Merli E, Rucker JC, Eggenberger ER, Zee DS, Cortelli P. Neuro‐ophthalmological findings in early fatal familial insomnia. Ann Neurol 2021;89(4):823–827. [DOI] [PubMed] [Google Scholar]
- 134. Yee RD, Farlow MR, Suzuki DA, Betelak KF, Ghetti B. Abnormal eye movements in Gerstmann‐Straussler‐Scheinker disease. Arch Ophthalmol 1992;110(1):68–74. [DOI] [PubMed] [Google Scholar]
- 135. Stell R, Bronstein AM, Marsden CD. Vestibulo‐ocular abnormalities in spasmodic torticollis before and after botulinum toxin injections. J Neurol Neurosurg Psychiatry 1989;52(1):57–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Hirsig A, Barbey C, Schupbach MWM, Bargiotas P. Oculomotor functions in focal dystonias: A systematic review. Acta Neurol Scand 2020;141(5):359–367. [DOI] [PubMed] [Google Scholar]
- 137. Demer JL, Holds JB, Hovis LA. Ocular movements in essential blepharospasm. Am J Ophthalmol 1990;110(6):674–682. [DOI] [PubMed] [Google Scholar]
- 138. Bollen E, Van Exel E, van der Velde EA, Buytels P, Bastiaanse J, van Dijk JG. Saccadic eye movements in idiopathic blepharospasm. Mov Disord 1996;11(6):678–682. [DOI] [PubMed] [Google Scholar]
- 139. Aramideh M, Bour LJ, Koelman JH, Speelman JD, Ongerboer de Visser BW. Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition. Clinical and pathophysiological considerations. Brain 1994;117(Pt 6):1457–1474. [DOI] [PubMed] [Google Scholar]
- 140. Barow E, Schneider SA, Bhatia KP, Ganos C. Oculogyric crises: Etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord 2017;36:3–9. [DOI] [PubMed] [Google Scholar]
- 141. FitzGerald PM, Jankovic J. Tardive oculogyric crises. Neurology 1989;39(11):1434–1437. [DOI] [PubMed] [Google Scholar]
- 142. Gold DR, Reich S. Oculogyric crisis. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6r53dvc. 2017.
- 143. Martinez‐Hernandez E, Arino H, McKeon A, et al. Clinical and immunologic investigations in patients with stiff‐person spectrum disorder. JAMA Neurol 2016;73(6):714–720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. Bernardo F, Rebordao L, Rego A, et al. Stiff person spectrum disorders: An illustrative case series of their phenotypic and antibody diversity. J Neuroimmunol 2020;341:577192. [DOI] [PubMed] [Google Scholar]
- 145. Floeter MK, Valls‐Sole J, Toro C, Jacobowitz D, Hallett M. Physiologic studies of spinal inhibitory circuits in patients with stiff‐person syndrome. Neurology 1998;51(1):85–93. [DOI] [PubMed] [Google Scholar]
- 146. Sandbrink F, Syed NA, Fujii MD, Dalakas MC, Floeter MK. Motor cortex excitability in stiff‐person syndrome. Brain 2000;123(Pt 11):2231–2239. [DOI] [PubMed] [Google Scholar]
- 147. Molloy FM, Dalakas MC, Floeter MK. Increased brainstem excitability in stiff‐person syndrome. Neurology 2002;59(3):449–451. [DOI] [PubMed] [Google Scholar]
- 148. Economides JR, Horton JC. Eye movement abnormalities in stiff person syndrome. Neurology 2005;65(9):1462–1464. [DOI] [PubMed] [Google Scholar]
- 149. Gold D. Gaze‐evoked nystagmus & slow saccades due to anti‐GAD antibodies in a patient with stiff person syndrome. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6jh8vwp. 2020.
- 150. Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S. Stiff eyes in stiff‐person syndrome. Neurology 2008;71(5):378–380. [DOI] [PubMed] [Google Scholar]
- 151. Vinjam MR, Shanmugarajan P, Ford H. Stiff person syndrome presenting as “stiff eyes”. J Neurol Neurosurg Psychiatry 2015;86(11):e4.125–e4.1e4. [Google Scholar]
- 152. Dalakas MC. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti‐GAD antibodies. J Neurol 2005;252(suppl 1):I19–I25. [DOI] [PubMed] [Google Scholar]
- 153. Ingster‐Moati I, Bui Quoc E, Pless M, Djomby R, Orssaud C, Guichard JP, Woimant F. Ocular motility and Wilson's disease: a study on 34 patients. J Neurol Neurosurg Psychiatry 2007;78(11):1199–1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Kirkham TH, Kamin DF. Slow saccadic eye movements in Wilson's disease. J Neurol Neurosurg Psychiatry 1974;37(2):191–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155. Lennox G, Jones R. Gaze distractibility in Wilson's disease. Ann Neurol 1989;25(4):415–417. [DOI] [PubMed] [Google Scholar]
- 156. Lesniak M, Czlonkowska A, Seniow J. Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease. Mov Disord 2008;23(14):2067–2073. [DOI] [PubMed] [Google Scholar]
- 157. Lasker AG, Zee DS. Ocular motor abnormalities in Huntington's disease. Vision Res 1997;37(24):3639–3645. [DOI] [PubMed] [Google Scholar]
- 158. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington's disease: slowing and dysmetria. Neurology 1988;38(3):427–431. [DOI] [PubMed] [Google Scholar]
- 159. Collewijn H, Went LN, Tamminga EP, Vegter‐Van der Vlis M. Oculomotor defects in patients with Huntington's disease and their offspring. J Neurol Sci 1988;86(2–3):307–320. [DOI] [PubMed] [Google Scholar]
- 160. Leigh RJ, Zee DS. The Neurology of Eye Movements. Philadelphia: F.A. Davis Co.; 1983. [Google Scholar]
- 161. Fekete R, Baizabal‐Carvallo JF, Ha AD, Davidson A, Jankovic J. Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls. J Neurol Neurosurg Psychiatry 2012;83(2):202–204. [DOI] [PubMed] [Google Scholar]
- 162. Kaski D, Bronstein AM. Functional eye movement disorders. Handb Clin Neurol 2016;139:343–351. [DOI] [PubMed] [Google Scholar]
- 163. Kaski D, Bronstein AM, Edwards MJ, Stone J. Cranial functional (psychogenic) movement disorders. Lancet Neurol 2015;14(12):1196–1205. [DOI] [PubMed] [Google Scholar]
- 164. Cogan DG, Freese CG Jr. Spasm of the near reflex. AMA Arch Ophthalmol 1955;54(5):752–759. [DOI] [PubMed] [Google Scholar]
- 165. Gold D Voluntary ocular flutter. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6t18rxj. 2017.
- 166. Wray SH Spasm of the near reflex. Neuro‐ophthalmology Virtual Education Library. https://collections.lib.utah.edu/ark:/87278/s6351gzw. 1982.
- 167. Zahn JR. Incidence and characteristics of voluntary nystagmus. J Neurol Neurosurg Psychiatry 1978;41(7):617–623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168. Blair CJ, Goldberg MF, Von Noorden GK. Voluntary nystagmus. Electro‐oculographic findings in four cases. Arch Ophthalmol 1967;77(3):349–354. [DOI] [PubMed] [Google Scholar]
- 169. Baizabal‐Carvallo JF, Jankovic J. Psychogenic ophthalmologic movement disorders. J Neuropsychiatry Clin Neurosci 2016;28(3):195–198. [DOI] [PubMed] [Google Scholar]
